Paul Pumpens
Riga, RIX, Latvia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The True Story and Advantages of RNA Phage Capsids as Nanotools.
Journal: Intervirology
Published: May 25, 2016
The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016
Journal: Molekuliarnaia biologiia
Published: January 14, 2016
The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Journal: Molecular biotechnology
Published: October 09, 2015
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
Journal: Scientific reports
Published: February 08, 2015
Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.
Journal: PloS one
Published: April 24, 2014
Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.
Journal: Molecular biotechnology
Published: February 27, 2014
Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.
Journal: Clinical and vaccine immunology : CVI
Published: September 06, 2013
A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.
Journal: PloS one
Published: April 29, 2013
Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
Journal: Journal of viral hepatitis
Published: August 07, 2012
Last Updated: 09/26/2026